Immunomodulatory effects of growth hormone administration are associated with improvement in myocardial contractile performance in dilated cardiomyopathy patients

被引:0
|
作者
Adamopoulos, S
Parissis, JT
Paraskevaidis, J
Karatzas, D
Kroupis, C
Livanis, E
Karavolias, G
Kremastinos, DT
机构
[1] Onassis Cardiac Surg Ctr, Athens, Greece
[2] Amalia Fleming Hosp, Athens, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:265A / 265A
页数:1
相关论文
共 50 条
  • [1] Growth hormone administration as immunomodulatory treatment in patients with idiopathic dilated cardiomyopathy: a randomized crossover study
    Adamopoulos, S
    Parissis, JT
    Georgiadis, M
    Karatzas, D
    Kroupis, C
    Paraskevaidis, J
    Livanis, E
    Kremastinos, D
    EUROPEAN HEART JOURNAL, 2002, 23 : 230 - 230
  • [2] Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy
    Adamopoulos, S
    Parissis, JT
    Paraskevaidis, I
    Karatzas, D
    Livanis, E
    Georgiadis, M
    Karavolias, G
    Mitropoulos, D
    Degiannis, D
    Kremastinos, DT
    EUROPEAN HEART JOURNAL, 2003, 24 (24) : 2186 - 2196
  • [3] Antiapoptotic effects of growth hormone are associated with improvement of left ventricular geometry in patients with heart failure secondary to idiopathic dilated cardiomyopathy
    Adamopoulos, S
    Parissis, J
    Karatzas, D
    Paraskevaidis, J
    Livanis, E
    Kremastinos, D
    CIRCULATION, 2004, 110 (17) : 599 - 600
  • [4] Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy
    R. A. Tio
    R. H. J. A. Slart
    R. A. de Boer
    P. A. van der Vleuten
    R. M. de Jong
    L. M. van Wijk
    T. Willems
    D. D. Lubbers
    A. A. Voors
    D. J. van Veldhuisen
    Netherlands Heart Journal, 2009, 17 : 470 - 474
  • [5] Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy
    Tio, R. A.
    Slart, R. H. J. A.
    de Boer, R. A.
    van der Vleuten, P. A.
    de Jong, R. M.
    van Wijk, L. M.
    Willems, T.
    Lubbers, D. D.
    Voors, A. A.
    van Veldhuisen, D. J.
    NETHERLANDS HEART JOURNAL, 2009, 17 (12) : 470 - 474
  • [6] Effectiveness of growth hormone in patients with dilated cardiomyopathy
    Ismailov, S. I.
    Mardanov, B. U.
    Nazarova, B. E.
    Abdullaev, T. A.
    Choi, I. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S147 - S147
  • [7] Beneficial effects of growth hormone in patients with Chagas cardiomyopathy and dilated cardiomyopathy of unknown etiology
    Beer, N
    Beer, TR
    Pinedo, M
    Fermin, E
    CIRCULATION, 1997, 96 (08) : 2920 - 2920
  • [8] Anti-remodel ling effects of growth hormone administration are associated with the reduction of abnormal peripheral immune responses in dilated cardiomyopathy patients
    Adamopoulos, S
    Parissis, JT
    Karatzas, D
    Paraskevaidis, J
    Livanis, E
    Kroupis, C
    Karavolias, G
    Kremastinos, D
    EUROPEAN HEART JOURNAL, 2003, 24 : 409 - 409
  • [9] Growth hormone treatment modulates circulating cytokine network and improves left-ventricular contractile performance in patients with dilated cardiomyopathy
    Adamopoulos, S
    Parissis, JT
    Paraskevaidis, J
    Karatzas, D
    Livanis, E
    Kroupis, C
    Karavolias, G
    Kremastinos, D
    EUROPEAN HEART JOURNAL, 2003, 24 : 190 - 190
  • [10] Preserved stress myocardial flow can predict of improvement of contractile function in the patients with non ischemic dilated cardiomyopathy
    Kong, E.
    Cho, I.
    Lee, C.
    Shin, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S184 - S185